128 related articles for article (PubMed ID: 26560069)
1. Estimation of Drug Binding to Brain Tissue: Methodology and in Vivo Application of a Distribution Assay in Brain Polar Lipids.
Belli S; Assmus F; Wagner B; Honer M; Fischer H; Schuler F; Alvarez-Sánchez R
Mol Pharm; 2015 Dec; 12(12):4529-41. PubMed ID: 26560069
[TBL] [Abstract][Full Text] [Related]
2. PK/PD assessment in CNS drug discovery: Prediction of CSF concentration in rodents for P-glycoprotein substrates and application to in vivo potency estimation.
Caruso A; Alvarez-Sánchez R; Hillebrecht A; Poirier A; Schuler F; Lavé T; Funk C; Belli S
Biochem Pharmacol; 2013 Jun; 85(11):1684-99. PubMed ID: 23454189
[TBL] [Abstract][Full Text] [Related]
3. Improving the in vitro prediction of in vivo central nervous system penetration: integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain.
Summerfield SG; Stevens AJ; Cutler L; del Carmen Osuna M; Hammond B; Tang SP; Hersey A; Spalding DJ; Jeffrey P
J Pharmacol Exp Ther; 2006 Mar; 316(3):1282-90. PubMed ID: 16330496
[TBL] [Abstract][Full Text] [Related]
4. Integrating in Silico and in Vitro Approaches To Predict Drug Accessibility to the Central Nervous System.
Zhang YY; Liu H; Summerfield SG; Luscombe CN; Sahi J
Mol Pharm; 2016 May; 13(5):1540-50. PubMed ID: 27015243
[TBL] [Abstract][Full Text] [Related]
5. Estimation of the unbound brain concentration of P-glycoprotein substrates or nonsubstrates by a serial cerebrospinal fluid sampling technique in rats.
Mariappan TT; Kurawattimath V; Gautam SS; Kulkarni CP; Kallem R; Taskar KS; Marathe PH; Mandlekar S
Mol Pharm; 2014 Feb; 11(2):477-85. PubMed ID: 24380373
[TBL] [Abstract][Full Text] [Related]
6. Use of plasma and brain unbound fractions to assess the extent of brain distribution of 34 drugs: comparison of unbound concentration ratios to in vivo p-glycoprotein efflux ratios.
Kalvass JC; Maurer TS; Pollack GM
Drug Metab Dispos; 2007 Apr; 35(4):660-6. PubMed ID: 17237155
[TBL] [Abstract][Full Text] [Related]
7. Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice.
Maurer TS; Debartolo DB; Tess DA; Scott DO
Drug Metab Dispos; 2005 Jan; 33(1):175-81. PubMed ID: 15502010
[TBL] [Abstract][Full Text] [Related]
8. Utility of unbound plasma drug levels and P-glycoprotein transport data in prediction of central nervous system exposure.
He H; Lyons KA; Shen X; Yao Z; Bleasby K; Chan G; Hafey M; Li X; Xu S; Salituro GM; Cohen LH; Tang W
Xenobiotica; 2009 Sep; 39(9):687-93. PubMed ID: 19569734
[TBL] [Abstract][Full Text] [Related]
9. A Practical Perspective on the Evaluation of Small Molecule CNS Penetration in Drug Discovery.
Huang L; Wells MC; Zhao Z
Drug Metab Lett; 2019; 13(2):78-94. PubMed ID: 30854983
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of using rat-derived single-dose neuropharmacokinetic parameters to project accurately large animal unbound brain drug concentrations.
Doran AC; Osgood SM; Mancuso JY; Shaffer CL
Drug Metab Dispos; 2012 Nov; 40(11):2162-73. PubMed ID: 22899853
[TBL] [Abstract][Full Text] [Related]
11. High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery.
Wan H; Rehngren M; Giordanetto F; Bergström F; Tunek A
J Med Chem; 2007 Sep; 50(19):4606-15. PubMed ID: 17725338
[TBL] [Abstract][Full Text] [Related]
12. Label-free assay for the assessment of nonspecific binding of positron emission tomography tracer candidates.
Assmus F; Seelig A; Gobbi L; Borroni E; Glaentzlin P; Fischer H
Eur J Pharm Sci; 2015 Nov; 79():27-35. PubMed ID: 26341407
[TBL] [Abstract][Full Text] [Related]
13. Examining the Uptake of Central Nervous System Drugs and Candidates across the Blood-Brain Barrier.
Summerfield SG; Zhang Y; Liu H
J Pharmacol Exp Ther; 2016 Aug; 358(2):294-305. PubMed ID: 27194478
[TBL] [Abstract][Full Text] [Related]
14. Use of the Distribution Coefficient in Brain Polar Lipids for the Assessment of Drug-Induced Phospholipidosis Risk.
Ceccarelli M; Wagner B; Alvarez-Sánchez R; Cruciani G; Goracci L
Chem Res Toxicol; 2017 May; 30(5):1145-1156. PubMed ID: 28398727
[TBL] [Abstract][Full Text] [Related]
15. Neuropharmacokinetics of two investigational compounds in rats: divergent temporal profiles in the brain and cerebrospinal fluid.
Tang C; Chen T; Kapadnis S; Hodgdon H; Tao Y; Chen X; Wen M; Costa D; Murphy D; Nolan S; Flood DG; Welty DF; Koenig G
Biochem Pharmacol; 2014 Oct; 91(4):543-51. PubMed ID: 25091561
[TBL] [Abstract][Full Text] [Related]
16. In vitro-to-in vivo prediction of P-glycoprotein-based drug interactions at the human and rodent blood-brain barrier.
Hsiao P; Bui T; Ho RJ; Unadkat JD
Drug Metab Dispos; 2008 Mar; 36(3):481-4. PubMed ID: 18057117
[TBL] [Abstract][Full Text] [Related]
17. Effect of P-glycoprotein-mediated efflux on cerebrospinal fluid concentrations in rhesus monkeys.
Tang C; Kuo Y; Pudvah NT; Ellis JD; Michener MS; Egbertson M; Graham SL; Cook JJ; Hochman JH; Prueksaritanont T
Biochem Pharmacol; 2009 Sep; 78(6):642-7. PubMed ID: 19481060
[TBL] [Abstract][Full Text] [Related]
18. Blood-brain barrier pharmacoproteomics-based reconstruction of the in vivo brain distribution of P-glycoprotein substrates in cynomolgus monkeys.
Uchida Y; Wakayama K; Ohtsuki S; Chiba M; Ohe T; Ishii Y; Terasaki T
J Pharmacol Exp Ther; 2014 Sep; 350(3):578-88. PubMed ID: 24947467
[TBL] [Abstract][Full Text] [Related]
19. Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method.
Longhi R; Corbioli S; Fontana S; Vinco F; Braggio S; Helmdach L; Schiller J; Boriss H
Drug Metab Dispos; 2011 Feb; 39(2):312-21. PubMed ID: 21071520
[TBL] [Abstract][Full Text] [Related]
20. Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery.
Kalvass JC; Maurer TS
Biopharm Drug Dispos; 2002 Nov; 23(8):327-38. PubMed ID: 12415573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
